Who Paid My Doc
Marina Wilder
Undersea and Hyperbaric Medicine Marietta, GA Medical Doctor
NPI 1164468443 CMS profile 7037
61 Whitcher St Ne, Suite 2150, Marietta, GA 30060
General payments
$137
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Marina Wilder of Marietta, GA is reported in the CMS Open Payments database as having received $137 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 22nd percentile of Undersea and Hyperbaric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $13 | 1 | |
| 2024 | General | $30 | 2 | |
| 2023 | General | $76 | 2 | |
| 2022 | General | $15 | 1 | |
| 2019 | General | $3 | 1 |
Beside peers
- Marina Wilder
- Undersea and Hyperbaric Medicine median
- Middle half of Undersea and Hyperbaric Medicine
- National median
In program year 2025, general payments to Marina Wilder were reported at $13. Among 121 Undersea and Hyperbaric Medicine profiles paid that year, the median was $208 and the middle half received between $52 and $518.
Show as a table
| Year | Marina Wilder | Undersea and Hyperbaric Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3 | $201 | $85–$538 | $163 |
| 2020 | $0 | $84 | $31–$222 | $114 |
| 2021 | $0 | $138 | $52–$383 | $132 |
| 2022 | $15 | $135 | $51–$385 | $149 |
| 2023 | $76 | $143 | $75–$442 | $160 |
| 2024 | $30 | $178 | $80–$442 | $164 |
| 2025 | $13 | $208 | $52–$518 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 15 billing codesPaid by Medicare
$358,683
Medicare patients
50
Services billed
3,312
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 60% | |
| Diabetes | 52% | |
| Arthritis | 48% | |
| Chronic kidney disease | 42% | |
| Heart failure | 36% | |
| Atrial fibrillation | 32% | |
| Depression | 22% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Undersea and Hyperbaric Medicine in Georgia
Norman McCulloch
Undersea and Hyperbaric Medicine · Winder, GA
Ricardo Duran
Undersea and Hyperbaric Medicine · Roswell, GA
William Lagaly
Undersea and Hyperbaric Medicine · Athens, GA
Daniel Beless
Undersea and Hyperbaric Medicine · Sandy Springs, GA
Helen Gelly
Undersea and Hyperbaric Medicine · Marietta, GA
Martin Lynch
Undersea and Hyperbaric Medicine · Rome, GA
Related records
Undersea and Hyperbaric Medicine in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Undersea and Hyperbaric Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.